Health Canada drug identification number

DIN 02366010 — HALOPERIDOL INJECTION 5 MG

HALOPERIDOL INJECTION is a solution of Haloperidol Decanoate marketed by JUNO PHARMA CANADA INC.. The full Haloperidol Decanoate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02366010
Brand name
HALOPERIDOL INJECTION
Active ingredient
Haloperidol Decanoate
Strength
5 MG
Dosage form
SOLUTION
Route
INTRAMUSCULAR
Manufacturer
JUNO PHARMA CANADA INC.
Health Canada status
MARKETED
Drug class
Butyrophenone antipsychotic (first-generation/typical antipsychotic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Haloperidol Decanoate products

DINBrandStrengthFormManufacturerStatus
02406411 HALOPERIDOL INJECTION, USP 5 MG SOLUTION FRESENIUS KABI CANADA LTD MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.